Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-27 10:27:04 - browse：26525

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： What we owe ALS patients — and why one company fell short

knowledge

hotspot

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Study: AI not yet building 'n

Flu, Covid vaccination rates decline, new survey data show

CDC wastewater surveillance dashboard to track bird flu hotspots

Study points to new risk in gene therapy death of Terry Horgan

Dairy farmers resist CDC push for PPE against bird flu virus

knowledge

Wikipedia

focus

Bright Health sells Medicare Advantage business to Molina

2023 Nobel Prize in Medicine goes to Karikó and Weissman

BioMarin wins approval for gene therapy to treat hemophilia A

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Anesthesiologist group: stop taking Ozempic before surgery

WHO recommends second malaria vaccine

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

First recipient of genetically engineered pig kidney has died

Drug repurposing or repositioning? The language matters

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

leisure time

European officials brace for rough respiratory virus season

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Dairy farmers resist CDC push for PPE against bird flu virus

Health insurers' Q3 question: how much care are people getting?

What will Novo Nordisk's VC do with its influx of cash?

After gene therapy, two congenitally deaf children hear for the first time

knowledge

hotspot

explore

knowledge